Recent findings reveal that C3a signaling contributes to type 2 immune responses by promoting expansion of group 2 innate lymphoid cells (ILC2s) in an HDM-induced mouse model of airway allergy (98). This evidence concerns the gene C3 and allergic respiratory disease.